Breaking News Bar

Business News and Information

How this Nasdaq-U.K.-listed Chinese biotech is revolutionizing cancer treatment

Chi-Med has been granted three U.S. Food and Drug Administration Fast Track Designations for its cancer drugs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear